DKS
DICK'S Sporting Goods, Inc.
DKS has lower modeled downside risk, despite its lower overall score.
F
Ford Motor Company
F has the edge over DKS overall, supported by stronger valuation.
DKS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Under pressure | |
| Healthy |
DKS's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
DKS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $84.34 | -42% |
| Forward | 12x | $146 | — |
| Fair | 14x | $124 | -15% |
| Current | 16x | $146 | — |
| Expensive | 18x | $162 | +11% |
Historical ranges are pointers, not guarantees.
DKS's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
DKS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect DKS's earnings to grow and its profitability to improve, with its revenue holding steady.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
DKS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.44 | +37% |
| Q3 2026 | $9.06 | -37% |
| Q2 2026 | $10.27 | -27% |
| Q1 2026 | $9.97 | -29% |
| Q4 2025 | $12.44 | -11% |
| Q3 2025 | $14.33 | +5.1% |
| Q2 2025 | $13.99 | +16% |
| Q1 2025 | $14.05 | +15% |
| Q4 2024 | $13.99 | +25% |
DKS has the edge over F on earnings quality, reporting a profit while its opponent remains loss making.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
DKS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.6B | +53% |
| Q2 2026 | $5.2B | +63% |
| Q1 2026 | $6.2B | +60% |
| Q4 2025 | $4.2B | +36% |
| Q3 2025 | $3.6B | +5% |
| Q2 2025 | $3.2B | +5.2% |
| Q1 2025 | $3.9B | +0.5% |
| Q4 2024 | $3.1B | +0.5% |
DKS has the edge over F on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | -4.5 points |
| Q2 2026 | 8.7% | -2.8 points |
| Q1 2026 | 3% | -7 points |
| Q4 2025 | 2.2% | -7.1 points |
| Q3 2025 | 12% | -1.1 points |
| Q2 2025 | 12% | +0.6 points |
| Q1 2025 | 9.9% | +0.3 points |
| Q4 2024 | 9.4% | +0.4 points |
DKS has the edge over F on profitability, with a higher operating margin.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F's revenue grew through 2023 and has held roughly level since: $49.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F's operating margin was 2.9% last quarter, about level with the same quarter a year ago.
DKS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $133M | -55% |
| Q2 2026 | -$84.2M | +$2.5M |
| Q1 2026 | $706.2M | +79% |
| Q4 2025 | -$515.6M | -$376.3M |
| Q3 2025 | $296.2M | +65% |
| Q2 2025 | -$86.7M | -217% |
| Q1 2025 | $394.5M | -33% |
| Q4 2024 | -$139.3M | -$49.6M |
DKS still generates free cash flow, though less than at its 2020 peak: $239M over the past year.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F has the edge over DKS on cash flow, with more consistent year-over-year improvement.
DKS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -277K shares |
| 1 year | +11% | +9.1M shares |
| 3 years | +3.9% | +3.3M shares |
| 5 years | -18% | -19.1M shares |
| Available history | +4.1% | +3.5M shares |
DKS has 90M diluted shares, up 11% from a year ago, despite $185M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $141.2M |
| Q1 2026 | $43.5M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $303.7M |
| Q1 2025 | $92.8M |
| Q4 2024 | $6.7M |
DKS spent $185M buying back its own shares over the past year, down 54% from the year before.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has the edge over DKS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
DKS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.0x | Very low |
DKS's net debt is less than a year of its operating earnings (EBITDA).
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over DKS on leverage, with a lower net debt burden relative to earnings.
DKS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.2 | Neutral |
| Stochastic | 24.3 | Neutral |
DKS's weekly RSI is 38 (neutral) and its Stochastic is 24 (neutral).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
DKS PE vs Consumer Cyclical Sector
| Metric | DKS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 71 | 47 | 24 pts above |
DKS is trading at 16x earnings, a 11% discount to the Consumer Cyclical sector's median of 18x.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
DKS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $141.1 | 3.3% above |
| 20 week MA | $166.3 | 12% below |
| 50 week MA | $194.2 | 25% below |
| 100 week MA | $202.5 | 28% below |
| 200 week MA | $184.0 | 21% below |
DKS has the edge over F on trend strength, trading above more of its moving averages.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
DKS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $55.6 | +15% |
| 2021 | $55.6 | $103.9 | +87% |
| 2022 | $103.9 | $111.1 | +6.9% |
| 2023 | $111.1 | $147.0 | +32% |
| 2024 | $147.0 | $234.1 | +59% |
| 2025 | $234.1 | $210.3 | -10% |
| 2026 YTD | $210.3 | $145.7 | -31% |
DKS is down 31% so far in 2026, after finishing higher in five of the previous six years.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F has the edge over DKS on returns for 2026, with the stronger performance.